Gout: Rapid Evidence Review

Area of Science:

• Rheumatology
• Crystal-induced arthropathies

Background:

• Gout results from monosodium urate crystal deposition in joints.
• Identified risk factors include male sex, obesity, hypertension, alcohol, diuretics, specific diets, chronic kidney disease, certain ethnicities, and high-income countries.

Purpose of the Study:

• To outline the causes, risk factors, and diagnostic approaches for gout.
• To detail therapeutic strategies for acute gout episodes and long-term management.

Main Methods:

• Review of established risk factors and clinical presentation of gout.
• Discussion of diagnostic criteria, including clinical prediction rules and synovial fluid analysis.
• Overview of pharmacological treatments for acute flares and chronic urate-lowering therapy.

Main Results:

• Gout presents as joint swelling and pain, potentially with tophi formation.
• Diagnosis relies on clinical prediction rules, with arthrocentesis for septic joint suspicion or diagnostic uncertainty.
• Acute gout episodes are managed with colchicine, NSAIDs, or corticosteroids.
• Long-term urate-lowering therapy is indicated for recurrent flares, tophi, or organ damage.

Conclusions:

• Gout management involves addressing acute symptoms and implementing long-term urate control.
• Allopurinol is a standard urate-lowering agent; febuxostat use is cautioned due to mortality risks.